Dr Wall said the Brazilian authorities could not meet the deadline set to deal with concerns over the use of microbials and illegal growth promoters set out by the European Commission

Scientific committees advising the EU have repeatedly concluded that oestradiol-17β must be considered a 'complete carcinogen'.